The four most significantly changed proteins (Fig. 1c) were midkine (MK), DOPA decarboxylase (DDC), interleukin-17D (IL17D) and mothers against decapentaplegic homolog 5 (MAD homolog 5), which were all elevated in PD compared with controls. This evidence concerns the gene SMAD5 and Parkinson disease.